Cutaneous Involvement in Plasma Cell Myeloma: Report of a Case.
Plasma cellmyeloma constitutes about 10% of all hematologic malignancies. Metastatic cutaneous lesions without underlying bony involvement are rare and associated with advanced disease, poor prognosis and high tumor burden. IgG is the most common subtype and IgD is believed to have a more aggressive course.